|
|
|
Fachinformationen für Ärzte
Ausgewählte wissenschaftliche Publikationen [ im .pdf-Format ]
| 32. |
Thomaseth K, Kautzky-Willer A, Ludvik B, Prager R, Pacini G: Integrated mathematical model to assess beta-cell activity during the oral glucose test. Am.J.Physiol 270:E522-E531, 1996
(2.36 MB) |
| 40. |
Ludvik B, Nolan JJ, Roberts A, Baloga J, Joyce M, Bell JM, Olefsky JM: Evidence for decreased splanchnic glucose uptake after oral glucose administration in non-insulin-dependent diabetes mellitus. J.Clin.Invest 100:2354-2361, 1997
(236 kB) |
| 42. |
Clodi M, Thomaseth K, Pacini G, Hermann K, Kautzky-Willer A, Waldhusl W, Prager R, Ludvik B: Distribution and kinetics of amylin in humans. Am.J.Physiol 274:E903-E908, 1998
(125 kB) |
| 44. |
Riedl M, Ludvik B, Pacini G, Clodi M, Kotzmann H, Wagner O, Kautzky-Willer A, Prager R, Luger A: The increased insulin sensitivity in growth hormone-deficient adults is reduced by growth hormone replacement therapy. Eur.J.Clin.Invest 30:771-778, 2000
(179 kB) |
| 45. |
Kautzky-Willer A, Pacini G, Tura A, Bieglmayer C, Schneider B, Ludvik B, Prager R, Waldhausl W: Increased plasma leptin in gestational diabetes. Diabetologia 44:164-172, 2001
(108 kB) |
| 46. |
Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ: A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care 24:539-548, 2001
(170 kB) |
| 47. |
Tura A, Ludvik B, Nolan JJ, Pacini G, Thomaseth K: Insulin and C-peptide secretion and kinetics in humans: direct and model-based measurements during OGTT. Am.J.Physiol Endocrinol.Metab 281:E966-E974, 2001
(202 kB) |
| 48. |
Ludvik B, Mahdjoobian K, Waldhaeusl W, Hofer A, Prager R, Kautzky-Willer A, Pacini G: The effect of Ipomoea batatas (Caiapo) on glucose metabolism and serum cholesterol in patients with type 2 diabetes: a randomized study. Diabetes Care 25:239-40, 2002
(137 kB) |
| 49. |
Georg P, Kautzky-Willer A, Mahdjoobian K, Hofer A, Prager R, Pacini G, Ludvik B: Influence of metabolic control on splanchnic glucose uptale, insulin sensitivity, and the time required for glucose absorption in patients with type 1 diabetes. Diabetes Care 25:2042-2047, 2002
(143 kB) |
| 50. |
Ludvik B, Thomaseth K, Nolan JJ, Clodi M, Prager R, Pacini G: Inverse relation between amylin and glucagon secretion in healthy and diabetic human subjects. Eur J Clin Invest 33:316-322, 2003
(215 kB) |
| 51. |
Tura A, Pacini G, Kautzky-Willer A, Ludvik B, Prager R, Thomaseth K: Basal and dynamic proinsulin-insulin relationship to assess {beta}-cell function during OGTT in metabolic disorders. Am J Physiol Endocrinol Metab 285:E155-E162, 2003
(285 kB) |
| 52. |
Ludvik B, Waldhaeusl W, Prager R, Kautzky-Willer A, Pacini G: Mode of Action of Ipomoea batatas (Caiapo) in type 2 diabetic patients. Metabolism 52:875-880, 2003
(108 kB) |
| 53. |
Pichler B, Ludvik B: Future perspectives of pharmacotherapy of obesity. Journal für Kardiologie 10:427-429, 2003
(290 kB) |
| 54. |
Ludvik B, Neuffer B, Pacini G: Efficacy of Ipomoea batatas (Caiapo) on diabetes control in type 2 diabetic patients. Diabetes Care 27:436-440, 2004
(98 kB) |
| 55. |
Schindler K, Prager G, Ballaban T, Kretschmer S, Riener R, Buranyi B, Maier C, Luger A, Ludvik B: The Impact of Laparoscopic Adjustable Gastric Banding (LABG) on Plasma Ghrelin, Eating Behaviour and Body Weight. European Journal of Clinical Investigation 34:549-554, 2004
(109 kB) |
| 56. |
Schindler K, Ludvik B: Methodische und praktische Aspekte der Bestimmung der Körperzusammensetzung [Assessment of Body Composition - methods and practical aspects]. Wien Med Wochenschr 154(13-14):305-12, 2004
(109 kB) |
| 57. |
Tripp B, Ludvik B: Medikamentöse Therapie der Adipositas [Pharmacotherapy of Obesity]. Wien Med Wochenschr 154(13-14):320-8, 2004
(120 kB) |
| 58. |
Bohdjalian A, Langer FB, Hoda A, Felberbauer FX , Silberhumer G, Zacherl J, Schindler K, Luger A, Ludvik B, Prager G: Chirurgische Therapie der Adipositas. Wien Med Wochenschr 154(13-14):329-33, 2004
(316 kB) |
| 59. |
Tripp B, Ludvik B: Neue Antiadiposita [Novel Anti-Obesity-Drugs]. Acta Medica Austriaca 31(4):133-138, 2004
(93 kB) |
| 60. |
Cauza E, Hanusch-Enserer U, Strasser B, Ludvik B, Metz-Schimmerl S, Pacini G, Wagner O, Georg P, Prager R, Kostner K, Dunky A, Haber P: The Relative Benefits of Endurance and Strength Training on the Metabolic Factors and Muscle Function of People with Type 2 Diabetes Mellitus. Arch Phys Med Rehabil 86(8):1527-33, 2005
(136 kB) |
| 61. |
Langer FB, Reza Hoda MA, Bohdjalian A, Felberbauer FX, Zacherl J, Wenzl E, Schindler K, Luger A, Ludvik B, Prager G: Sleeve Gastrectomy and Gastric Banding: Effects on Plasma Ghrelin Levels. Obes Surg 15(7):1024-9, 2005
(156 kB) |
| 62. |
Cauza E, Hanusch-Enserer U, Strasser B, Ludvik B, Kostner K, Dunky A, Haber P: Continuous Glucose Monitoring in Diabetic Long Distance Runners. Int J Sports Med 26(9):774-80, 2005
(Abstract, GIF 80 kB) |
| 63. |
Abrahamian H, Ludvik B, Schernthaner G, Prager R, Zellenka U, Knudsen L, Wascher T: Improvement of glucose tolerance in type 2 diabetic patients: traditional vs. modern insulin regimens (results from the Austrian Biaspart Study). Horm Metab Res 37(11):684-9, 2005
(n.a.) |
| 64. |
Haider DG, Schindler K, Schaller G, Prager G, Wolzt M, Ludvik B: Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding. J Clin Endocrinol Metab. 91(4):1578-81, 2006
(n.a.) |
| 65. |
Langer FB, Bohdjalian A, Felberbauer FX, Fleischmann E, Reza Hoda MA, Ludvik B, Zacherl J, Jakesz R, Prager G: Does gastric dilatation limit the success of sleeve gastrectomy as a sole operation for morbid obesity? Obes Surg 16 (2):166-71, 2006
(n.a.) |
| 66. |
Bohdjalian A, Prager G, Aviv R, Policker S, Schindler K, Kretschmer S, Riener R, Zacherl J, Ludvik B: One year experience with Tantalus™: a New Surgical Approach to Treat Morbid Obesity. Obes Surg 16(5):627-34, 2006
(n.a.) |
| 67. |
Kautzky-Willer A, Tura A, Winzer C, Wagner OF, Ludvik B, Hanusch-Enserer U, Prager R, Pacini G: Insulin sensitivity during oral glucose tolerance test and its relations to parameters of glucose metabolism and endothelial function in type 2 diabetic subjects under metformin and thiazolidinedione. Diabetes Obes Metab 8(5):561-7, 2006
(n.a.) |
| 68. |
Schindler K, Haider D, Wolzt M , Rieger A, Gmeinhart B, Luger A, Nowotny P, Ludvik B: Impact of Antiretroviral Therapy on Visfatin and Retinol Binding Protein 4 in HIV+ Subjects. Eur J Clin Invest 36(9):640-6, 2006
(n.a.) |
| 69. |
Riener R, Schindler K, Ludvik B: Psychosocial Variables, Eating Behavior, Depression and Binge Eating in Morbidly Obese Subjects. Eating Behaviors 7(4):309-14, 2006
(n.a.) |
| 70. |
Dorner T, Fodor JG, Lawrence K, Ludvik B, Rieder A: HDL-knowledge in the lay public: results of a representative population survey. Atherosclerosis 195(1):195-8, 2007
(n.a.) |
| 71. |
Haider DG, Schindler K, Prager G, Bohdjalian A, Luger A, Wolzt M, Ludvik B: Serum retinolbinding protein 4 is reduced after weight loss in morbidly obese subjects. J Clin Endocrinol Metab 92(3):1168-71, 2007
(n.a.) |
| 72. |
Haider DG, Schindler K, Mittermayer F, Müller M, Nowotny P, Rieger A, Ludvik B, Wolzt M: Effect of rosiglitazone on visfatin and retinol binding protein-4 plasma concentrations in HIV-positive patients. Clin Pharmacol Ther 81(4):580-5 , 2007
(n.a.) |
| 73. |
Haider DG, Schindler K, Bohdjalian A, Prager G, Luger A, Wolzt M, Ludvik B: Plasma adipocyte and epidermal fatty acid binding protein is reduced after weight loss in obesity. Diabetes Obes Metab 9(5):761-3, 2007
(n.a.) |
| 74. |
Tripp B, Ludvik B: Antihypertensive and metabolic effects of telmisartan in patients with the metabolic syndrome in primary care--a field study. Wien Med Wochenschr 157(9-10):223-7, 2007 [German]
(n.a.) |
| 75. |
Anderwald C, Anderwald-Stadler M, Promintzer M, Prager G, Mandl M, Nowotny P, Bischof MG, Wolzt M, Ludvik B, Kästenbauer T, Pacini G, Luger A, Krebs M: The Clamp-Like Index: a novel and highly sensitive insulin sensitivity index to calculate hyperinsulinemic clamp glucose infusion rates from oral glucose tolerance tests in nondiabetic subjects. Diabetes Care 30(9):2374-80, 2007
(n.a.) |
| 76. |
Vila G, Maier C, Riedl M, Nowotny P, Ludvik B, Luger A, Clodi M: Bacterial endotoxin induces biphasic changes in plasma ghrelin in healthy humans. J Clin Endocrinol Metab 92(10):3930-4, 2007
(n.a.) |
| 77. |
Kollmann A, Riedl M, Kastner P, Schreier G, Ludvik B: Feasibility of a mobile phone-based data service for functional insulin treatment of type 1 diabetes mellitus patients. J Med Internet Res 9(5):e36, 2007
(n.a.) |
| 78. |
Ludvik B, Hanefeld M, Pacini G: Improved Metabolic Control by Ipomoea (Caiapo) is Associated with Increased Adiponectin and Decreased High Sensitive C-reactive Protein and Fibrinogen Levels in type 2 diabetic subjects. Diabetes Obes Metab 10(7):586-92, 2008
(100 kB) |
| 79. |
Kiefer FW, Zeyda M, Todoric J, Huber J, Geyeregger R, Weichhart T, Aszmann O, Ludvik B, Silberhumer GR, Prager G, Stulnig TM: Osteopontin expression in human and murine obesity: extensive local up-regulation in adipose tissue but minimal systemic alterations. Endocrinology 149(3):1350-7, 2008
(n.a.) |
| 80. |
Riedl M, Vila G, Maier C, Handisurya A, Shakeri-Manesch S, Prager G, Wagner O, Kautzky-Willer A, Ludvik B, Clodi M, Luger A: Plasma osteopontin increases after bariatric surgery and correlates with markers of bone turnover but not with insulin resistance. J Clin Endocrinol Metab 93(6):2307-12, 2008
(n.a.) |
| 81. |
Morak J, Schindler K, Goerzer E, Kastner P, Toplak H, Ludvik B, Schreier G: A pilot study of mobile phone-based therapy for obese patients. J Telemed Telecare 14(3):147-9, 2008
(n.a.) |
| 82. |
Langer FB, Bohdjalian A, Shakeri-Manesch S, Felberbauer FX, Ludvik B, Zacherl J, Prager G: Inadequate Weight Loss vs Secondary Weight Regain: Laparoscopic Conversion from Gastric Banding to Roux-en-Y Gastric Bypass. Obes Surg, 2008, published online
(n.a.) |
| 83. |
Brema I, Hatunic M, Finucane F, Burns N, Nolan JJ, Haider D, Wolzt M, Ludvik B: Plasma visfatin is reduced after aerobic exercise in early onset type 2 diabetes mellitus. Diabetes Obes Metab 10(7):600-2, 2008
(n.a.) |
| 84. |
Huber J, Kiefer FW, Zeyda M, Ludvik B, Silberhumer GR, Prager G, Zlabinger GJ, Stulnig TM: CC chemokine and CC chemokine receptor profiles in visceral and subcutaneous adipose tissue are altered in human obesity. J Clin Endocrinol Metab, 2008, published online
(n.a.) |
| 85. |
Maier C, Riedl M, Vila G, Nowotny P, Wolzt M, Clodi M, Ludvik B, Luger A: Cholinergic regulation of ghrelin and PYY release may be impaired in obesity. Diabetes, 2008, published online
(n.a.) |
| 86. |
Bohdjalian A, Ludvik B, Guerci B, Bresler L, Renard E, Nocca D, Karnieli E, Assalia A, Prager R, Prager: Improvement in glycemic control by
gastric electrical stimulation (TANTALUS(TM)) in overweight subjects with type 2 diabetes. G.Surg Endosc, 2008, [Epub ahead of print]
(n.a.) |
| 87. |
Vila G, Riedl M, Maier C, Struck J, Morgenthaler NG, Handisurya A, Prager G, Ludvik B, Clodi M, Luger A: Plasma MR-proADM Correlates to BMI and Decreases in Relation to Leptin After Gastric Bypass Surgery. Obesity (Silver Spring), 2009, [Epub ahead of print]
(n.a.) |
| 88. |
Schindler K, Rieger A, Tura A, Gmeinhardt B, Touzeau-Römer V, Haider D, Pacini G, Ludvik B: The Effect of Rosiglitazone on Insulin Sensitivity, Beta Cell Function, Bone Mineral Density, and Body Composition in HIV-positive Patients on Highly-active Antiretroviral Therapy (HAART). Horm Metab Res, 2009, [Epub ahead of print]
(n.a.) |
|
|
|
Was bringt körperliche Aktivität bei Adipositas? (13 kB)
Fachinformationen für Ärzte
